Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Early onset hair loss linked to genetics and androgen levels.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Testosterone helps human pancreatic cells increase insulin release.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Testosterone is crucial for development, growth, and various body functions in mammals.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Longer CAG repeats in gene linked to more severe hair loss in females.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride effectively blocks enzyme causing male pattern baldness.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.